✨ Free AI Report
Epigenomics AG: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Epigenomics AG
Research Preview

Epigenomics AG: Business Overview, Financials & Competitive Analysis

Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using DNA methylation technology. The company focuses on liquid biopsy for the earl...

Analyst-debate audio for Epigenomics AG

AskCyborg analysts argue the bull and bear cases for Epigenomics AG across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Epigenomics AG OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
5/ 10Mixed

Cyborg Score thesis

Potential value play in cancer diagnostics, contingent on successful Epi proColon commercialization and pipeline...

Read the full analyst-debate transcript →
Industry In-Vitro Diagnostics
3 named competitors
2 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: September 28, 2026
AI-Verified Research
30+ Page Report

Get the Latest Epigenomics AG Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Epigenomics AG Overview

Pro stress-test →

Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using DNA methylation technology. The company focuses on liquid biopsy for the early detection of cancer, with its lead product Epi proColon, a blood-based test for early detection of colorectal cancer in the United States, Europe, and China.

Strategic Profile

Pro stress-test →

The company leverages proprietary DNA methylation technology to develop non-invasive blood tests for cancer screening and monitoring across multiple cancer indications. Epigenomics competes in the emerging liquid biopsy market, positioning itself as a developer of diagnostic tests that enable earlier cancer detection through accessible blood sampling rather than more invasive procedures.

Competitive Landscape

Pro stress-test →

Epigenomics competes in the liquid biopsy and molecular diagnostics space against established diagnostics companies and specialized biotech firms developing blood-based cancer tests. Key competitors include companies offering alternative detection technologies (ctDNA-based assays, protein biomarkers) and larger diagnostics platforms integrating multiple cancer detection methods.

Industry Context

Epigenomics AG operates in In-Vitro Diagnostics.

Key facts

Founded: 2002 · Headquarters: Berlin, Germany · Employees: N/A · Revenue: N/A · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Epigenomics AG.

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Epigenomics AG has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

Guardant Health platformLiquid biopsy and circulating tumor DNA testing→Exact SciencesMolecular diagnostics and early cancer detection→Foundation MedicineGenomic profiling and liquid biopsy testing→

Compare Epigenomics AG with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Epigenomics AG operates in In-Vitro Diagnostics. See how the rest of the sector scores on the Cyborg framework.

Browse In-Vitro Diagnostics research →
NEW · MCP server

Ask your AI assistant about Epigenomics AG

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Epigenomics AG and its top competitor on Cyborg Score”
“What did Epigenomics AG do this quarter?”
“Is Epigenomics AG a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Epigenomics AG do?+
Epigenomics AG is a Germany-based molecular diagnostics company focused on blood-based detection, prognosis and monitoring of cancers using DNA methylation technology. The company focuses on liquid biopsy for the earl...
What is Epigenomics AG's Cyborg Score?+
Epigenomics AG has a Cyborg Score of 5/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Epigenomics AG's main competitors?+
Named competitors include Guardant Health platform, Exact Sciences, Foundation Medicine. The full competitive landscape is in the AskCyborg report.
How can I get the full Epigenomics AG research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Epigenomics AG research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Epigenomics AG over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

More In-Vitro Diagnostics research

Companies in the same sector and named competitors, ranked by Cyborg Score.

7DiaSorin S.p.A.7Shenzhen New Industries Biomedical Engineering Co., Ltd.4Biosynex SA